Why the study?
What are the hemodynamic effects of isoproterenol and metaraminol in patients with severe cardiogenic shock?
What are the hemodynamic effects of isoproterenol and metaraminol in patients with severe cardiogenic shock?
Isoproterenol and metaraminol demonstrate distinct hemodynamic profiles in severe cardiogenic shock, highlighting the need for tailored pharmacological support based on individual hemodynamic deficits.
Answers are grounded in this paper and cite their sources.
May inform agent selection by profile in shock; hypothesis-generating for outcome trials.
In 14 subjects with severe cardiogenic shock the characteristic findings before treatment were hypotension, low cardiac output, and increased central venous pressure, with normal values for total peripheral resistance. Oliguria, lactic acidosis, hypocapnia, and hypoxemia also were present. These changes were interpreted as reflecting acute heart failure in association with a peripheral vascular response which was inadequate to maintain normal blood pressure. Isoproterenol caused a decrease in venous pressure and an increase in cardiac output. In most cases this was sufficient to increase blood pressure, despite slight reductions in peripheral vascular resistance. In a few cases, however, the inotropic effect of the drug was so small that the reduction in vascular resistance caused a further fall in arterial pressure. Metaraminol caused elevation of venous pressure, peripheral resistance, and blood pressure at the expense of some reduction of cardiac output. An approach to therapy is discussed in the light of these findings.
No takes yet. Share an insight, caveat, or question.
Smith et al. (1967) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: